SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-136028
Filing Date
2021-11-09
Accepted
2021-11-09 08:03:04
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132381d1_8k.htm   iXBRL 8-K 28940
2 EXHIBIT 99.1 tm2132381d1_ex99-1.htm EX-99.1 63614
3 GRAPHIC image_001.jpg GRAPHIC 3915
  Complete submission text file 0001104659-21-136028.txt   281090

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elox-20211109.xsd EX-101.SCH 3198
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20211109_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20211109_pre.xml EX-101.PRE 22719
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132381d1_8k_htm.xml XML 3512
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 211389966
SIC: 8731 Services-Commercial Physical & Biological Research